HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincenzo Fasanella Selected Research

Macular Degeneration (Age-Related Maculopathy)

1/2015Intravitreal ranibizumab for predominantly hemorrhagic choroidal neovascularization in age-related macular degeneration.
10/2012Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincenzo Fasanella Research Topics

Disease

17Glaucoma
11/2017 - 07/2008
4Blister (Bulla)
11/2017 - 06/2008
4Inflammation (Inflammations)
01/2017 - 06/2011
3Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2015 - 07/2008
2Low Tension Glaucoma
01/2018 - 02/2015
2Macular Degeneration (Age-Related Maculopathy)
01/2015 - 10/2012
2Choroidal Neovascularization
01/2015 - 10/2012
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2018
1Dry Eye Syndromes (Dry Eye Syndrome)
03/2015
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
03/2013
1Hypersensitivity (Allergy)
02/2013
1Choroidal Effusions
12/2010
1Ocular Hypertension (Glaucoma, Suspect)
07/2008

Drug/Important Bio-Agent (IBA)

2Indicators and Reagents (Reagents)IBA
10/2016 - 01/2016
2Biomarkers (Surrogate Marker)IBA
01/2015 - 06/2013
2Proteins (Proteins, Gene)FDA Link
06/2013 - 04/2012
1Retinaldehyde (Retinal)IBA
01/2018
1CytokinesIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
03/2015
1HLA-DR Antigens (HLA-DR)IBA
03/2015
1Ranibizumab (Lucentis)FDA Link
01/2015
1tafluprostIBA
08/2013
1Prostaglandins AIBA
06/2013
1Fluorescein (Funduscein)FDA LinkGeneric
03/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012
1GoldIBA
12/2010
1hydroxide ionIBA
07/2008
1Antiglaucoma AgentsIBA
06/2008

Therapy/Procedure

10Therapeutics
03/2015 - 06/2008
6Lasers (Laser)
11/2017 - 03/2013
6Filtering Surgery
11/2017 - 06/2011
1Contact Lenses
02/2015
1Injections
01/2015
1Aftercare (After-Treatment)
01/2014